Answers are grounded in this paper and cite their sources.
Observational analysis reveals CARM1 enhances MAP2K4 activity in breast cancer, suggesting a targetable dependency.
Reverse expression patterns of CARM1 and MAP2K4 in breast cancer subtypes and CARM1-mediated MAP2K4 methylation potentiates the downstream JNK activation
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: